KC
ENFN

Kintayl Capital’s Enfusion, Inc. ENFN Stock Holding History

Kintayl Capital’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-75,365
Closed -$840K – 52
2025
Q1 		$840K Buy
+75,365
New +$833K 0.59% 31

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Kintayl Capital's ENFN Position: Q2 2025 in Review

Kintayl Capital sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 75,365 shares — an estimated $840K sold.

Kintayl Capital first reported a position in ENFN in Q1 2025 and held it in 1 quarter. The position peaked at $840K in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Kintayl Capital reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Kintayl Capital sold 75,365 Enfusion, Inc. shares in Q2 2025, an estimated $840K.
  • Kintayl Capital first reported a position in Enfusion, Inc. in Q1 2025 and held it in 1 quarter.
  • Kintayl Capital's Enfusion, Inc. position peaked at $840K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Kintayl Capital's 13F filing for Q2 2025, filed 14 Aug 2025.